A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation. (Q33330147)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation. |
scientific article |
Statements
A phase I evaluation of multitargeted antifolate (MTA, LY231514), administered every 21 days, utilizing the modified continual reassessment method for dose escalation (English)
Rinaldi DA
Kuhn JG
Burris HA
Dorr FA
Rodriguez G
Eckhardt SG
Jones S
Woodworth JR
Langley C
Mascorro D
Abrahams T
1 January 1999